Page 49 - 《中国药房》2024年6期
P. 49

鼠曲草抗慢性阻塞性肺疾病的质量标志物筛选
                                                                                 Δ


                                                           1 #
                 1*
          刘婉婷 ,谢 榕 ,林达淮 ,叶向丽 ,严国鸿 ,李 煌 (1.福建中医药大学药学院,福州 350122;2.福建医科
                                                   3
                                          2
                          1
                                  1
          大学附属协和医院呼吸内科,福州 350001;3.福建中医药大学附属人民医院药学部,福州 350004)
          中图分类号  R917      文献标志码  A      文章编号  1001-0408(2024)06-0683-06
          DOI  10.6039/j.issn.1001-0408.2024.06.08
          摘  要  目的  筛选鼠曲草抗慢性阻塞性肺疾病(COPD)的质量标志物并测定其含量。方法  通过网络药理学以“鼠曲草”为检索
          条件预测其抗COPD的有效成分及靶点。采用《中药色谱指纹图谱相似度评价系统(2012年版)》建立10批鼠曲草药材(S1~S10)
          的高效液相色谱(HPLC)指纹图谱,指认共有峰,进行相似度评价;并进行聚类分析、主成分分析和正交偏最小二乘-判别分析,以
          变量重要性投影(VIP)>1为标准筛选影响鼠曲草质量的差异性成分作为质量标志物。采用同一HPLC法测定10批样品中上述
          差异性成分的含量。结果  网络药理学检索得到槲皮素、木犀草素、绿原酸等黄酮类和有机酸类共10种主要活性成分,与抗COPD
          密切相关的靶点有91个。10批样品中共指认出9个共有峰,相似度均大于0.90,其中绿原酸、咖啡酸、1,3-O-二咖啡酰基奎尼酸、
          芹菜素7-O-β-D-吡喃葡萄糖苷为差异性成分;S3、S4、S6、S7、S10聚为一类,S2、S5、S8、S9聚为一类,S1聚为一类。10批鼠曲草药
          材中绿原酸、咖啡酸、1,3-O-二咖啡酰基奎尼酸、芹菜素7-O-β-D-吡喃葡萄糖苷的含量分别为0.070~7.653、0.010~0.097、0.001~
          0.036、0.508~6.627 mg/g。结论  绿原酸、咖啡酸、1,3-O-二咖啡酰基奎尼酸、芹菜素7-O-β-D-吡喃葡萄糖苷可作为鼠曲草的潜在
          质量标志物,其中绿原酸成分含量以江西吉安产鼠曲草最高,咖啡酸成分含量以江西吉安与福建三明产鼠曲草最高,后两种成分
          含量以广东潮汕产鼠曲草最高。
          关键词  鼠曲草;靶点预测;指纹图谱;慢性阻塞性肺疾病;质量标志物

          Screening of anti-COPD quality biomarkers of Gnaphalium affine
                                                                      3
                                                       2
                                                                                1
          LIU Wanting ,XIE Rong ,LIN Dahuai ,YE Xiangli ,YAN Guohong ,LI Huang(1. School of Pharmacy, Fujian
                     1
                                           1
                               1
          University  of  Traditional  Chinese  Medicine,  Fuzhou  350122,  China;2.  Dept.  of  Respiratory  Medicine,  Fujian
          Medical  University  Union  Hospital,  Fuzhou  350001,  China;3.  Dept.  of  Pharmacy,  the  Affiliated  People’s
          Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou 350004, China)
          ABSTRACT   OBJECTIVE  To  screen  the  quality  biomarkers  of  Gnaphalium  affine  with  anti-chronic  obstructive  pulmonary
          disease (COPD)  effect  and  determine  their  contents.  METHODS  The  effective  components  and  targets  of “G.  affine”  with  anti-
          COPD  effect  were  predicted  by  using  network  pharmacology  as  a  search  criterion.  HPLC  fingerprints  for  10  batches  of  G.  affine
          were  established  by  using  Similarity  Evaluation  System  of  TCM  Chromatographic  Fingerprint (2012  edition);  common  peak
          identification  and  similarity  evaluation  were  conducted;  cluster  analysis (CA),  principal  component  analysis (PCA),  and
          orthogonal  partial  least  squares-discriminant  analysis (OPLS-DA)  were  performed  to  screen  differential  components  as  quality
          maker that affected the quality of G. affine using variable importance projection (VIP)>1 as the standard. The same HPLC method
          was adopted to determine the contents of the differential components in 10 batches of samples. RESULTS A total of 10 flavonoids
         (such  as  quercetin,  luteolin,  and  chlorogenic  acid)  and  organic  acid  components,  were  identified  through  network  pharmacology
          search,  with  91  targets  closely  related  to  anti-COPD. A  total  of  9  common  peaks  were  identified  in  10  batches  of  samples,  with
          similarity  greater  than  0.90.  Among  them,  the  differential  components  included  chlorogenic  acid,  caffeic  acid,  1,3-O-
          dicaffeoylquinic acid and apigenin 7-O-β-D-glucopyranoside; S3, S4, S6, S7 and S10 were clustered into one category, S2, S5,
          S8 and S9 clustered into one category, and S1 clustered into one category. The contents of chlorogenic acid, caffeic acid, 1,3-O-
          dicaffeoylquinic  acid,  and  apigenin  7-O-β-D-glucopyranoside  in  10  batches  of  G.  affine  ranged  0.070-7.653,  0.010-0.097,  0.001-
          0.036, 0.508-6.627 mg/g, respectively. CONCLUSIONS  Chlorogenic acid, caffeic acid, 1,3-O-dicaffeoylquinic acid, apigenin 7-
          O-β-D-glucopyranoside can serve as the potential quality marker for the anti-COPD effect of G. affine, with the highest content of
                                                             chlorogenic  acid  in  G.  affine  produced  in  Ji’an,  Jiangxi
             Δ 基金项目 福建省自然科学基金面上项目(No.2023J01670);福
                                                             province,  and  the  highest  content  of  caffeic  acid  in  G.  affine
          建省科技计划引导性项目(No.2022Y0036);福建省卫生健康面向农村
                                                             produced  in  Ji’an,  Jiangxi  province  and  Sanming,  Fujian
          和城市社区推广适宜技术资助项目(No.2022TG008)
             *第一作者 硕士研究生。研究方向: 中药药效物质基础。E-                   province.  The  contents  of  the  last  two  components  are  highest
          mail:a775095377@163.com                            in G. affine produced in Chaoshan, Guangdong province.
             # 通信作者 副教授,硕士生导师,博士。研究方向: 中药药效物                 KEYWORDS     Gnaphalium  affine;  target  prediction;  finger-
          质基础。E-mail:lhfjtcm@163.com                         print; COPD; quality marker


          中国药房  2024年第35卷第6期                                                 China Pharmacy  2024 Vol. 35  No. 6    · 683 ·
   44   45   46   47   48   49   50   51   52   53   54